SARS-CoV-2 PCR Test Results

Patient ID Full Name Date of Birth Gender

31017234810269362 Gerardo Tornes Fabián 02-10-1988 Male

Specimen Type Specimen Collected Specimen Received Reported

Antigen 01-03-2022 01-03-2022 01-03-2022

Passport No Endogenous Control Testing Personnel

Passed G.S.

Molecular Assays
Pathogen Result Reference Interval

Coronavirus COVID-19 Negative Not Detected

Clinical Significance

A negative result indicates that antigens from SARS-CoV-2 were not detected in the specimen above the limit of detection. This does notpreclude SARS-CoV-2 infection and shou
be used as the sole basis for patient management decisions. Antigen tests are known to be less sensitive than molecular tests. Negative results should be considered presumptiv
confirmed with an RT-PCR test. A negative speciment means that the detection part of the test was done correctly, but no COVID-19 antigen was detected

Next Steps
The information contained in this report is intended to be interpreted concurrently with clinical symptoms by a licensed physician or other licensed healthcare professional. The re
is not intended to take the place of professional medical advice.

Methodology

The BinaxNOWTM COVID-19 Ag Card is an immunochromatographic membrane assay that uses highly sensitive antibodies to detect SARS-CoV-2 nucleocapsid protein from nasa
swab specimens. SARS-CoV-2 specific antibodies and a control antibody are immobilized onto a membrane support as two distinct lines and combined with other reagents/pads
construct a test strip. This test strip and a well to hold the swab specimen are mounted on opposite sides of a cardboard, book-shaped hinged test card.

Limitations
The performance of this test was established based on the evaluation of a limited number of clinical specimens collected in November 2020. The clinical performance has not be
established in all circulating variants but is anticipated to be reflective of the prevalent variants in circulation at the time and location of the clinical evaluation. Performance at the
of testing may vary depending on the variants circulating, including newly emerging strains of SARS-CoV-2 and their prevalence, which change over time.

Notes

Antigen tests are immunoassays that detect the presence of a specific viral antigen, which implies current viral infection. Antigen tests for SARS-CoV-2 are generally less sensitiv
real-time reverse transcription polymerase chain reaction (RT-PCR) and other nucleic acid amplification tests (NAATs) for detecting the presence of viral nucleic acid. However, NA
can remain positive for weeks to months after initial infection and can detect levels of viral nucleic acid even when virus cannot be cultured, suggesting that the presence of viral
acid may not always indicate contagiousness.